ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance. ORIC's lead program, ORIC-101, is a potent and selective small molecule antagonist of the...
ORIC Pharmaceuticals is hiring an experienced Associate Director of Process Chemistry to lead scale-up, tech transfer, and GMP manufacturing activities for its oncology small-molecule pipeline.
ORIC is hiring a Director to lead CMC development and commercialization of rinzimetostat, driving integrated technical, regulatory, and external manufacturing strategies to enable clinical and commercial success.